Cover Image

Cancer Therapy Resistance: Choosing Kinase Inhibitors

Recent advances in comprehending the essential molecular mechanisms that govern cancer signaling have revealed the pivotal involvement of kinases in the development and progression of various cancer types [...]

Saved in:

Bibliographic Details
Main Authors:	Carmela Dell'Aversana (Author), Federica Sarno (Author), Rosaria Benedetti (Author), Wouter Leonard Megchelenbrink (Author), Donato Cappetta (Author)
Format:	Book
Published:	MDPI AG, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer
by: Shangwei Zhong, et al.
Published: (2022)

Extracellular Vesicle-Based Nucleic Acid Delivery: Current Advances and Future Perspectives in Cancer Therapeutic Strategies
by: Crescenzo Massaro, et al.
Published: (2020)

Emotional Regulation Interventions on Developmental Course for Preterm Children: A Systematic Review of Randomized Control Trials
by: Vincenza Dell'Aversana, et al.
Published: (2023)

Head and neck cancer management in the Covid-19 era: Our experience
by: Paola Bonavolontà, et al.
Published: (2021)

Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: a review
by: Giuseppe Di Costanzo, et al.
Published: (2023)

Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy
by: Wennan Zhao, et al.
Published: (2017)

Mechanisms of acquired resistance to tyrosine kinase inhibitors
by: Yi-fan Chen, et al.
Published: (2011)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
by: Lihua Huang, et al.
Published: (2015)

Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
by: Aisha Alsfouk
Published: (2021)

Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy
by: Nikolaos Kokkorakis, et al.
Published: (2024)

Emerging roles of Aurora-A kinase in cancer therapy resistance
by: Dayong Zheng, et al.
Published: (2023)

The Role of the Kinase Inhibitors in Thyroid Cancers
by: Francesca Cuomo, et al.
Published: (2022)

Protein and metabolic profiles of tyrosine kinase inhibitors co-resistant liver cancer cells
by: Zengbin Wang, et al.
Published: (2024)

Unlocking Potential and Limits of Kinase Inhibitors: The Highway to Enhanced Cancer Targeted Therapy
by: Francesca Musumeci, et al.
Published: (2024)

Resistance to PARP-inhibitors in Cancer Therapy
by: Alicia eMontoni, et al.
Published: (2013)

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
by: Lei Jiang, et al.
Published: (2023)

Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy
by: Xiaoli Pan, et al.
Published: (2022)

Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges
by: Isha Bansal, et al.
Published: (2023)

Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
by: Xiaohan Zhou, et al.
Published: (2020)

Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro
by: Bourn J, et al.
Published: (2018)

Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy
by: Josef Jampilek, et al.
Published: (2022)

Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux
by: Lucie Čermáková, et al.
Published: (2022)

Primary Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs): Contexts and Comparisons in EGFR-Mutated Lung Cancer
by: Keigo Kobayashi
Published: (2023)

Biomimetic Magnetic Nanocarriers Drive Choline Kinase Alpha Inhibitor inside Cancer Cells for Combined Chemo-Hyperthermia Therapy
by: Ylenia Jabalera, et al.
Published: (2019)

Nanoparticle-based targeted therapy through EGFR tyrosine kinase inhibitors and their recent advances in lung cancer therapy
by: Priyanka S. Waghmare, et al.
Published: (2024)

Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
by: Frontiers Production Office
Published: (2023)

Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
by: E. V. Artamonova, et al.
Published: (2019)

Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy
by: Somayyeh Ghareghomi, et al.
Published: (2023)

Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer
by: Huafeng Jiang, et al.
Published: (2023)

Choosing the Path of Leadership in Occupational Therapy
by: Clark Patrick Heard D.OT Reg. (Ont.)
Published: (2014)

The Kinase Specificity of Protein Kinase Inhibitor Peptide
by: Yao Chen, et al.
Published: (2021)

Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells
by: Zhuo-Xun Wu, et al.
Published: (2021)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
by: Zhe Zhang, et al.
Published: (2019)

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients
by: Anastasia Putri, et al.
Published: (2019)

Hallmarks of Anaplastic Lymphoma Kinase Inhibitors with Its Quick Emergence of Drug Resistance
by: Yong-Fu Qiu, et al.
Published: (2022)

Which thiazide to choose as add-on therapy for hypertension?
by: Barrios V, et al.
Published: (2014)

Innovations in the systemic treatment of medullary thyroid cancer with kinase inhibitors
by: Wiktoria Lipczyńska, et al.
Published: (2023)

Therapeutic Potential of Mitotic Kinases' Inhibitors in Cancers of the Gastrointestinal System
by: Aadil Javed, et al.
Published: (2022)

Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
by: Panupong Mahalapbutr, et al.
Published: (2024)

Lung Cancer: Biomarkers, Tyrosine Kinase Inhibitors and Monoclonal Antibodies
by: Made Putra Semadhi, et al.
Published: (2017)